A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber) on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial

A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber) on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial - A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019076

Enrollment

Registered

2015-09-19

Start date

2015-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

test food with resistant glucan (single ingestion) - washout period - placebo food without resistant glucan (single ingestion) placebo food without resistant glucan (single ingestion) - washout period

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Males and females from 20 to 64 years of age 2) Subjects falling under any of the following A. fasting blood glucose levels are ranged 110 to 125 mg/dL B. postprandial blood glucose levels are ranged from 140 mg/dL to 199 mg/dL

Exclusion criteria

Exclusion criteria: 1) Subjects who routinely use food rich in dietary fiber 2) Subjects routinely taking medicine or health food which may influence glucose metabolism 3) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) 4) Subjects having possibilities for emerging allergy related to the study 5) Subjects who are under medication or having a history of serious diseases for which medication was required 6) Subjects who have fasting blood glucose more than 126 mg/dL on preliminary examination 7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination 8) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 9) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating 10) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire 11) Subjects judged as unsuitable for the study by the investigator for other reasons

Design outcomes

Primary

Measure	Time frame
area under the curve of plasma glucose	—

Secondary

Measure	Time frame
Postprandial blood glucose, maximum plasma glucose level, insulin	—

Countries

Japan

Contacts

Public ContactHiroyasu Shimada

TTC Co., Ltd. Clinical Research Planning Department

h.shimada@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026